首页> 美国政府科技报告 >Novel gene C17orf37 in Prostate Cancer Progression and Metastasis: A Prospective Biomarker
【24h】

Novel gene C17orf37 in Prostate Cancer Progression and Metastasis: A Prospective Biomarker

机译:新型基因C17orf37在前列腺癌进展和转移中:一种前瞻性生物标志物

获取原文

摘要

The project focuses on novel gene named Chromosome 17 open reading frame 37 (C17orf37) in prostate cancer progression and metastasis. Although the gene is overexpressed in different forms of cancer, its expression and role in prostate cancer is poorly understood. The Aims of the project are to (1) To establish the correlation of C17orf37 protein expression with poor pathological and prognostic variables in prostatic adenocarcinomas, and (2) To directly demonstrate the biological consequences of C17orf37 overexpression in promoting prostate tumor metastasis and elucidate the molecular mechanisms regulating the process in vivo. This is the first annual report, and we have identified that C17orf37 is overexpressed in prostate cancer patients compared to normal prostatic tissues. We also discovered that overexpression of C17orf37 potentiates migration and invasion of prostate cancer cells through Akt/NF-kB downstream target genes. We have also established the stable cell lines expressing C17orf37, and currently evaluating role of C17orf37 in prostate cancer metastasis.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号